{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-004223","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2026-08-21T20:21:14+00:00","discovered_at":"2026-08-21T20:22:31.285068+00:00","generated_at":"2026-08-21T20:22:55.475716+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Silexion receives Nasdaq delisting notice for equity shortfall; plans appeal","bullets":["Nasdaq delisting notice received Aug 18, 2026 for failure to meet $2.5M shareholders' equity requirement (Rule 5550(b)(1)).","Shareholders' equity as of June 30, 2026 was only $44,000, far below required minimum.","Company intends to appeal by Aug 25, 2026; under Mandatory Hearings Panel Monitor limiting compliance extensions.","If appeal fails, ordinary shares and warrants (SLXN, SLXNW) will be suspended and delisted via Form 25-NSE."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-004223","json":"https://secwatch.observer/filing/0001178913-26-004223.json","markdown":"https://secwatch.observer/filing/0001178913-26-004223.md","text":"https://secwatch.observer/filing/0001178913-26-004223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004223/0001178913-26-004223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004223/zk2635995.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T20:22:55.475716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}